CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies

Affective Neuroscience: The Foundations of Human and Animal Emotions

Panksepp, J. (1998) · doi:10.1093/oso/9780195096736.001.0001 · Cited by 4,428 · see citing works

Handbook of Chemical Neuroanatomy

Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,159 · see citing works

Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain

Marsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937 · see citing works

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

Hökfelt, T. G. M., Rehfeld, J. F., Skirboll, L. R., IVEMARK, B. I., Goldstein, M., & MARKEY, K. (1980) · Nature · doi:10.1038/285476a0 · Cited by 707 · see citing works

The NPY system in stress, anxiety and depression

Heilig, M. A. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.002 · Cited by 617 · see citing works

Neuropeptides — an overview

Hökfelt, T. G. M., Broberger, C., Xu, Q., Sergeyev, V., Ubink, R., & Diez, M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00010-1 · Cited by 607 · see citing works

The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay

Beinfeld, M. C., Meyer, D., Eskay, R. L., Jensen, R. T., & Brownstein, M. (1981) · Brain Research · doi:10.1016/0006-8993(81)90031-7 · Cited by 551 · see citing works

Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense Oligodeoxynucleotides

Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F., & Heilig, M. A. (1993) · Science · doi:10.1126/science.8380941 · Cited by 524 · see citing works

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.

Hughes, J. W., Boden, P., Costall, B., Domeney, A. M., Kelly, E., Horwell, D. C., Hunter, J. C., Pinnock, R. D., & Woodruff, G. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6728 · Cited by 501 · see citing works

Different data from different labs: Lessons from studies of gene–environment interaction

Wahłsten, D., Metten, P., Phillips, T. J., Boehm, S. L., Burkhart‐Kasch, S., Dorow, J. D., Doerksen, S., Downing, C., Fogarty, J., Rodd‐Henricks, K., et al. (2002) · Journal of Neurobiology · doi:10.1002/neu.10173 · Cited by 495 · see citing works

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

Holmes, A., Heilig, M. A., Rupniak, N. M. J., Steckler, T., & Griebel, G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.09.011 · Cited by 401 · see citing works

Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models

Heilig, M. A., S�derpalm, B., Engel, J. A., & Widerl�v, E. (1989) · Psychopharmacology · doi:10.1007/bf00441953 · Cited by 390 · see citing works

The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y

Kask, A., Harro, J., von Hörsten, S., Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00066-5 · Cited by 358 · see citing works

Enhanced Sensitivity to Cholecystokinin Tetrapeptide in Panic Disorder

Bradwejn, J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310021005 · Cited by 344 · see citing works

Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive

Chesler, E. J., Wilson, S. G., Lariviere, W. R., Rodriguez-Zas, S. L., & Mogil, J. S. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00103-3 · Cited by 331 · see citing works

Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration

Piazza, P. V., Rougé‐Pont, F., Deminière, J. M., Kharouby, M., Moal, M. L., & Simon, H. (1991) · Brain Research · doi:10.1016/0006-8993(91)91452-7 · Cited by 326 · see citing works

Corticotropin-releasing factor and neuropeptide y: role in emotional integration

Heilig, M. A., Koob, G. F., Ekman, R., & Britton, K. T. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90079-5 · Cited by 324 · see citing works

Cholecystokinin Tetrapeptide Induces Panic-like Attacks in Healthy Volunteers

de Montigny, C. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810060031006 · Cited by 323 · see citing works

Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression

Thorsell, A., Michalkiewicz, M., Dumont, Y., Quirion, R., Caberlotto, L., Rimondini, R., Mathé, A. A., & Heilig, M. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220232997 · Cited by 315 · see citing works

Cholecystokinin-Tetrapeptide Induces Panic Attacks in Patients with Panic Disorder

Bradwejn, J., Koszycki, D., & Meterissian, G. B. (1990) · The Canadian Journal of Psychiatry · doi:10.1177/070674379003500115 · Cited by 293 · see citing works

Textbook of Biological Psychiatry

(2003) · Wiley eBooks · doi:10.1002/0471468975 · Cited by 278 · see citing works

CCK in animal and human research on anxiety

Harro, J., Vasar, E., & Bradwejn, J. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90020-k · Cited by 275 · see citing works

Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test

Sajdyk, T. J., Vandergriff, M. G., & Gehlert, D. R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00018-7 · Cited by 241 · see citing works

Diazepam-Binding Inhibitor: A Neuropeptide Located in Selected Neuronal Populations of Rat Brain

Alho, H., Costa, E., Ferrero, P., Fujimoto, M., Cosenza-Murphy, D., & Guidotti, A. (1985) · Science · doi:10.1126/science.3892688 · Cited by 232 · see citing works

Molecular evolution of NPY receptor subtypes

Larhammar, D., & Salaneck, E. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.06.002 · Cited by 217 · see citing works

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.

Singh, L., Lewis, A. S., Field, M. J., Hughes, J. W., & Woodruff, G. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1130 · Cited by 213 · see citing works

Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures

Broqua, P., Wettstein, J. G., Rocher, M. N., Gauthier-Martin, B., & Junien, J. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199504000-00001 · Cited by 198 · see citing works

Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones

Bradwejn, J., & de Montigny, C. (1984) · Nature · doi:10.1038/312363a0 · Cited by 192 · see citing works

Interactions between NPY and CRF in the amygdala to regulate emotionality

Sajdyk, T. J., Shekhar, A., & Gehlert, D. R. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.006 · Cited by 183 · see citing works

The Panicogenic Effects of Cholecystokinin-Tetrapeptide Are Antagonized by L-365,260, a Central Cholecystokinin Receptor Antagonist, in Patients With Panic Disorder

Bradwejn, J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950060050005 · Cited by 181 · see citing works

Reduced anxiety and improved stress coping ability in mice lacking NPY‐Y2 receptors

Tschenett, A., Singewald, N., Carli, M., Balducci, C., Salchner, P., Vezzani, A., Herzog, H., & Sperk, G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02725.x · Cited by 180 · see citing works

Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers

Benkelfat, C., Bradwejn, J., Meyer, E., Ellenbogen, M. A., Milot, S., GJEDDE, A. H., & Evans, A. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1180 · Cited by 171 · see citing works

Is There a Future for Neuropeptide Receptor Ligands in the Treatment of Anxiety Disorders?

Griebel, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00041-2 · Cited by 171 · see citing works

Neuropeptide Y Inhibits Hypocretin/Orexin Neurons by Multiple Presynaptic and Postsynaptic Mechanisms: Tonic Depression of the Hypothalamic Arousal System

Fu, L., Acuna, C., & van den Pol, A. N. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2268-04.2004 · Cited by 168 · see citing works

Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior

Suzuki, M., Beuckmann, C. T., Shikata, K., Ogura, H., & Sawai, T. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.002 · Cited by 161 · see citing works

Cholecystokinin and endogenous opioid peptides: Interactive influence on pain, cognition, and emotion

Hebb, A. L. O., Poulin, J.-F., Roach, S. P., Zacharko, R. M., & Drolet, G. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.008 · Cited by 160 · see citing works

Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress

Thorsell, A., Carlsson, K., Ekman, R., & Heilig, M. A. (1999) · Neuroreport · doi:10.1097/00001756-199909290-00024 · Cited by 157 · see citing works

Neuronal Cholecystokinin: One or Multiple Transmitters?

Rehfeld, J. F. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07105.x · Cited by 157 · see citing works

Reduced Neuropeptide Y Concentrations in Suicide Brain

Widdowson, P. S., Ordway, G. A., & Halaris, A. E. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08877.x · Cited by 155 · see citing works

The Neurochemistry of Behavior

Panksepp, J. (1986) · Annual Review of Psychology · doi:10.1146/annurev.ps.37.020186.000453 · Cited by 154 · see citing works

A Cholecystokinin-Mediated Pathway to the Paraventricular Thalamus Is Recruited in Chronically Stressed Rats and Regulates Hypothalamic-Pituitary-Adrenal Function

Bhatnagar, S., Viau, V., Chu, A., Soriano, L., Meijer, O. C., & Dallman, M. F. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-14-05564.2000 · Cited by 152 · see citing works

Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus

Harro, J., & Oreland, L. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00082-0 · Cited by 149 · see citing works

Neuropeptide Y (NPY) and depression: From animal studies to the human condition

Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02159-8 · Cited by 146 · see citing works

Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry

Singewald, N., & Sharp, T. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00177-9 · Cited by 145 · see citing works

Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats

Sajdyk, T. J., Schober, D. A., & Gehlert, D. R. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00234-4 · Cited by 141 · see citing works

Cholecystokinin Activates Orexin/Hypocretin Neurons through the Cholecystokinin A Receptor

Tsujino, N., Yamanaka, A., Ichiki, K., Muraki, Y., Kilduff, T. S., Yagami, K., Takahashi, S., Goto, K., & Sakurai, T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1193-05.2005 · Cited by 139 · see citing works

Cholecystokinin Antianalgesia: Safety Cues Abolish Morphine Analgesia

Wiertelak, E. P., Maier, S. F., & Watkins, L. R. (1992) · Science · doi:10.1126/science.256.5058.830 · Cited by 137 · see citing works

Multiple cholecystokinin receptors in the CNS

Winn, P. (1994) · Neuropsychologia · doi:10.1016/0028-3932(94)90059-0 · Cited by 134 · see citing works

Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice

Redrobe, J. P., Dumont, Y., Herzog, H., & Quirion, R. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00374-1 · Cited by 131 · see citing works

Blockade of CCK-sub(B) but not CCK-sub(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: Implications for anxiety associated with posttraumatic stress disorder.

Adamec, R. E., Shallow, T., & Budgell, J. (1997) · Behavioral Neuroscience · doi:10.1037//0735-7044.111.2.435 · Cited by 127 · see citing works

Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation

Sørensen, G., Lindberg, C., Wörtwein, G., Bolwig, T. G., & Woldbye, D. P. D. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20200 · Cited by 124 · see citing works

Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test

Heilig, M. A., McLeod, S., Koob, G. K., & Britton, K. T. (1992) · Regulatory Peptides · doi:10.1016/0167-0115(92)90514-u · Cited by 123 · see citing works

Involvement of Cholecystokininergic Systems in Anxiety-Induced Hyperalgesia in Male Rats: Behavioral and Biochemical Studies

André, J., Zeau, B., Pohl, M., Cesselin, F., Benoliel, J. J., & Becker, C. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0743-05.2005 · Cited by 121 · see citing works

Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1‐selective antagonist BIBP3226

Kask, A., Rägo, L., & Harro, J. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701969 · Cited by 119 · see citing works

Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt

Westrin, Å., Ekman, R., & Träskman‐Bendz, L. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00026-1 · Cited by 119 · see citing works

A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder

Kramer, M. S., Cutler, N. R., Ballenger, J. C., Patterson, W. M., Mendels, J., Chenault, A., Shrivastava, R. K., Matzura‐Wolfe, D., Lines, C., & Reines, S. A. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00190-e · Cited by 117 · see citing works

Blockade of CCKB but not CCKA receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: Implications for anxiety associated with posttraumatic stress disorder.

Adamec, R. E., Shallow, T., & Budgell, J. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.2.435 · Cited by 111 · see citing works

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients

van Megen, H. J. G. M., Westenberg, H. G. M., den Boer, J. A., Haigh, J. R. M., & Traub, M. (1994) · Psychopharmacology · doi:10.1007/bf02249335 · Cited by 109 · see citing works

Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics

Harro, J., Kiivet, R. A., Lang, A., & Vasar, E. (1990) · Behavioural Brain Research · doi:10.1016/0166-4328(90)90121-t · Cited by 109 · see citing works

Cholecystokinin antianalgesia: safety cues abolish morphine analgesia

Wiertelak, E. P., Maier, S. F., & Watkins, L. R. (1992) · Science · doi:10.1126/science.1589765 · Cited by 103 · see citing works

Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats.

Kask, A., Rägo, L., & Harro, J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00076-6 · Cited by 101 · see citing works

Effects of Altered Amygdalar Neuropeptide Y Expression on Anxiety-Related Behaviors

Primeaux, S. D., Wilson, S. P., Cusick, M. C., York, D. A., & Wilson, M. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300705 · Cited by 101 · see citing works

Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress

Thorsell, A., Svensson, P., Wiklund, L., Sommer, W. H., Ekman, R., & Heilig, M. A. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00075-5 · Cited by 100 · see citing works

Anxiolytic activity of NPY receptor agonists in the conflict test

Britton, K. T., Southerland, S., Uden, E. V., Kirby, D., Rivier, J., & Koob, G. F. (1997) · Psychopharmacology · doi:10.1007/s002130050313 · Cited by 98 · see citing works

Regulation of Neuropeptide Y Release by Neuropeptide Y Receptor Ligands and Calcium Channel Antagonists in Hypothalamic Slices

King, P., Widdowson, P. S., Doods, H. N., & Williams, G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730641.x · Cited by 98 · see citing works

Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam

Kask, A., Rägo, L., & Harro, J. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00838-2 · Cited by 97 · see citing works

Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation

Harro, J., Oreland, L., Vasar, E., & Bradwejn, J. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)80003-k · Cited by 92 · see citing works

Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats

Wang, H., Wong, P. T. ‐., Spiess, J., & Zhu, Y. Z. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.05.008 · Cited by 89 · see citing works

Association study of 90 candidate gene polymorphisms in panic disorder

Maron, E., Nikopensius, T., K??ks, S., Altm??e, S., Heinaste, E., Vabrit, K., Tammekivi, V., Hallast, P., Koido, K., Kurg, A., et al. (2005) · Psychiatric Genetics · doi:10.1097/00041444-200503000-00004 · Cited by 89 · see citing works

Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat

Harro, J., & Vasar, E. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90156-k · Cited by 86 · see citing works

Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety

Kask, A., Nguyen, H. P., Pabst, R., & von Hörsten, S. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00116-6 · Cited by 86 · see citing works

Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment

Harro, J., P�ld, M., & Vasar, E. (1990) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00195059 · Cited by 85 · see citing works

Enhanced Cortical Extracellular Levels of Cholecystokinin-Like Material in a Model of Anticipation of Social Defeat in the Rat

Becker, C., Thiébot, M.-H., Touitou, Y., Hamon, M., Cesselin, F., & Benoliel, J. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00262.2001 · Cited by 84 · see citing works

Activation of Amygdala CholecystokininBReceptors Potentiates the Acoustic Startle Response in the Rat

Frankland, P. W., Josselyn, S. A., Bradwejn, J., Vaccarino, F. J., & Yeomans, J. S. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01838.1997 · Cited by 81 · see citing works

Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex

R�go, L. K., Kiivet, R., Harro, J., & P�ld, M. (1988) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00175795 · Cited by 79 · see citing works

A Double-Blind, Placebo-Controlled Study of a CCK-B Receptor Antagonist, CI-988, in Patients With Generalized Anxiety Disorder

Adams, J. B., Pyke, R. E., Costa, J., Cutler, N. R., Schweizer, E. E., Wilcox, C. S., Wisselink, P., Greiner, M., Pierce, M., & Pande, A. C. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199512000-00007 · Cited by 79 · see citing works

The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients

van Megen, H. J. G. M., Westenberg, H. G. M., den Boer, J. A., Slaap, B. R., Radhakishun, F. S., & Pande, A. C. (1997) · Psychopharmacology · doi:10.1007/s002130050186 · Cited by 75 · see citing works

Altered Hippocampal Expression of Neuropeptides in Seizure‐prone GALR1 Knockout Mice

Fetissov, S. O., Jacoby, A. S., Brumovsky, P. R., Shine, J., Iismaa, T. P., & Hökfelt, T. G. M. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.51402.x · Cited by 74 · see citing works

CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects

Lydiard, R. B., Ballenger, J. C., Laraia, M. T., Fossey, M. D., & Beinfeld, M. C. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.5.691 · Cited by 73 · see citing works

Behavioral Profile of CCK2 Receptor- deficient Mice

Daugé, V. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00291-3 · Cited by 71 · see citing works

Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain

Harro, J., Lang, A., & Vasar, E. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90594-v · Cited by 71 · see citing works

Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze

Rex, A., Fink, H., & Marsden, C. A. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90087-6 · Cited by 70 · see citing works

Regional brain cholecystokinin changes as a function of friendly and aggressive social interactions in rats

Panksepp, J., Burgdorf, J., Beinfeld, M. C., Kroes, R. A., & Moskal, J. R. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.076 · Cited by 68 · see citing works

Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.

Kask, A., Rägo, L., & Harro, J. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00076-7 · Cited by 67 · see citing works

Anxiogenic Effect of Cholecystokinin in the Dorsal Periaqueductal Gray

Netto, C. F., & Guimarães, F. S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300334 · Cited by 64 · see citing works

Typology of common psychiatric syndromes

Sullivan, P. F., & Kendler, K. S. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.173.4.312 · Cited by 61 · see citing works

Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse

Chen, Q., Nakajima, A., Meacham, C. E., & Tang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505407103 · Cited by 60 · see citing works

Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala

Belcheva, I., Belcheva, S., Petkov, V. P., & Petkov, V. P. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90158-9 · Cited by 59 · see citing works

Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L‐365,260.

Lines, C., Challenor, J., & Traub, M. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04442.x · Cited by 58 · see citing works

α-Helical CRF9-41 prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats

Kask, A., Rägo, L., & Harro, J. (1997) · Neuroreport · doi:10.1097/00001756-199711100-00044 · Cited by 57 · see citing works

Anxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment1Parts of this data was presented at the 4th IUPHAR Satellite Meeting on Serotonin, Rotterdam, July 23–25, 1998.1

To, C., & Bagdy, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00176-2 · Cited by 56 · see citing works

NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test

Kask, A., Rägo, L., & Harro, J. (1998) · Neuroreport · doi:10.1097/00001756-199808240-00005 · Cited by 54 · see citing works

Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder

Pande, A. C., Greiner, M., Adams, J. B., Lydiard, R. B., & Pierce, M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00090-6 · Cited by 54 · see citing works

The Effects of Cholecystokinin A and B Receptor Antagonists on Exploratory Behaviour in the Elevated zero-maze in Rat

Matto, V., Harro, J., & Allikmets, L. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00011-7 · Cited by 53 · see citing works

Alterations in brain cholecystokinin receptors in suicide victims

Harro, J., Marcusson, J. O., & Oreland, L. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90037-9 · Cited by 52 · see citing works

Changes in brain cholecystokinin and anxiety-like behavior following exposure of mice to predator odor

Hebb, A. L. O., Zacharko, R. M., Domínguez, H., Laforest, S., Gauthier, M. S., Levac, C., & Drolet, G. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00710-8 · Cited by 51 · see citing works

Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice

Johnson, N. J., & Rodgers, R. J. (1996) · Psychopharmacology · doi:10.1007/bf02247441 · Cited by 51 · see citing works

Cholecystokinin in CSF from depressed patients: possible relations to severity of depression and suicidal behaviour

Löfberg, C., Ågren, H., Harro, J., & Oreland, L. (1998) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00046-1 · Cited by 51 · see citing works

Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y1 receptor antagonist BIBO 3304

Kask, A., & Harro, J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00199-9 · Cited by 48 · see citing works

Regional brain cholecystokinin changes as a function of rough-and-tumble play behavior in adolescent rats

Burgdorf, J. S., Panksepp, J., Beinfeld, M. C., Kroes, R. A., & Moskal, J. R. (2005) · Peptides · doi:10.1016/j.peptides.2005.07.005 · Cited by 45 · see citing works

Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder

Hösing, V. G., Schirmacher, A., Kuhlenbäumer, G., Freitag, C. M., Sand, P. G., Schlesiger, C., Jacob, C., Fritze, J., Franke, P. E., Rietschel, M., et al. (2004) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-0579-5_17 · Cited by 44 · see citing works

The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze

Bickerdike, M. J., Marsden, C. A., Dourish, C. T., & Fletcher, A. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90800-1 · Cited by 43 · see citing works

Behavioral effects of neuropeptide Y in F344 rat substrains with a reduced dipeptidyl-peptidase IV activity

Karl, T., Hoffmann, T., Pabst, R., & von Hörsten, S. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00154-0 · Cited by 43 · see citing works

The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens

Ladurelle, N., Roques, B., & Daugé, V. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-04-03118.1995 · Cited by 41 · see citing works

Future of Neuropeptides in Biological Psychiatry and Emotional Psychopharmacology: Goals and Strategies

Panksepp, J., & Harro, J. (2003) · Wiley eBooks · doi:10.1002/0471468975.ch21 · Cited by 39 · see citing works

Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue

Tovote, P., Meyer, M., Beck‐Sickinger, A. G., von Hörsten, S., Ögren, S. O., Spiess, J., & Stiedl, O. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.03.011 · Cited by 39 · see citing works

The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze

Hinks, G. L., Brown, P., Field, M. J., Poat, J. A., & Hughes, J. M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00471-2 · Cited by 39 · see citing works

Stimulation of corticotropin release by pentagastrin in normal subjects and patients with panic disorder

Abelson, J. L., Nesse, R. M., & Vinik, A. I. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90330-o · Cited by 37 · see citing works

Decreased CCK B receptor binding in rat amygdala in animals demonstrating greater anxiety-like behavior

Wunderlich, G. R., Raymond, R., DeSousa, N. J., Nobrega, J. X. E., & Vaccarino, F. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1181-4 · Cited by 37 · see citing works

Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs

Dawson, G. R., Rupniak, N. M. J., Iversen, S. D., Curnow, R., Tye, S. J., Stanhope, K. J., & Tricklebank, M. D. (1995) · Psychopharmacology · doi:10.1007/bf02245597 · Cited by 35 · see citing works

Cholecystokinin peptides and receptors in the rat brain during stress

Harro, J., L�fberg, C., Rehfeld, J., & Oreland, L. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168707 · Cited by 32 · see citing works

Textbook of Biological Psychiatry

Sagduyu, K. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.636-a · Cited by 32 · see citing works

Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the rat

Kask, A., Eller, M. M., Oreland, L., & Harro, J. (2000) · Neuropeptides · doi:10.1054/npep.1999.0788 · Cited by 31 · see citing works

Strain differences in freezing behavior of PVG hooded and Sprague–Dawley rats: differential cortical expression of cholecystokinin2 receptors

Farook, J. M., Zhu, Y. Z., Wang, H., Moochhala, S., Lee, L., & Wong, P. T.-H. (2001) · Neuroreport · doi:10.1097/00001756-200108280-00025 · Cited by 31 · see citing works

Neuropeptide Y Y1 receptor antagonist BIBP3226 produces conditioned place aversion in rats

Kask, A., Kivastik, T., Rägo, L., & Harro, J. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00029-9 · Cited by 28 · see citing works

Leptin decreases feeding and exploratory behaviour via interactions with CCK1 receptors in the rat

Buyse, M., Bado, A., & Daugé, V. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00010-7 · Cited by 28 · see citing works

Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement

Phillips, G. D., LENOURY, J., Wolterink, G., Donselaar-Wolterink, I., Robbins, T. W., & Everitt, B. J. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90118-a · Cited by 27 · see citing works

Area postrema lesions elevate NPY levels and decrease anxiety-related behavior in rats

Miller, C. C., Holmes, P. V., & Edwards, G. L. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00847-8 · Cited by 26 · see citing works

CCK‐4‐Induced Calcium Mobilization in T Cells Is Enhanced in Panic Disorder

Akiyoshi, J., Moriyama, T., Isogawa, K., Miyamoto, M., Sasaki, I., 久我貴代美, Yamamoto, H., Yamada, K., & Fujii, I. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66041610.x · Cited by 25 · see citing works

Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers

Aluoja, A., Shlik, J., Vasar, V., Kingisepp, P., Jagomägi, K., Vasar, E., & Bradwejn, J. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(96)02948-4 · Cited by 24 · see citing works

Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat

Wunderlich, G. R., DeSousa, N. J., & Vaccarino, F. J. (2000) · Psychopharmacology · doi:10.1007/s002130000445 · Cited by 23 · see citing works

Prevention by 5-HT1A receptor agonists of restraint stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat

Becker, C. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00209-3 · Cited by 22 · see citing works

The benzodiazepine receptor inverse agonist FG 7142 induces cholecystokinin gene expression in rat brain

Pratt, J. A., & Brett, R. R. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11205-w · Cited by 22 · see citing works

Improved event-related potential signs of selective attention after the administration of the cholecystokinin analog ceruletide in healthy persons

Schreiber, H., Stolz-Born, G., Pietrowsky, R., Kornhuber, H. H., Fehm, H. L., & Jan Born, A. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00207-j · Cited by 21 · see citing works

Regulation of CCK mRNA expression in the rat brain by stress and treatment with sertraline, a selective serotonin re-uptake inhibitor

Giardino, L., Bettelli, C., Pozza, M., & Calzà, L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01242-1 · Cited by 20 · see citing works

Pentagastrin test for anxiety – psychophysiology and personality

Radu, D., Åhlin, A., Svanborg, P., & Lindefors, N. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1316-7 · Cited by 19 · see citing works

Benzodiazepines increase preprocholecystokinin messenger RNA levels in rat brain

Rattray, M., Singhvi, S., Wu, P., Andrews, N., & File, S. E. (1993) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(93)90129-w · Cited by 19 · see citing works

Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex

Harper, E. A., Griffin, E. P., Shankley, N. P., & Black, J. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702448 · Cited by 19 · see citing works

Clomipramine and clonazepam increase cholecystokinin levels in rat ventral tegmental area and limbic regions

Brodin, K., Ögren, S. O., & Brodin, E. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90538-x · Cited by 18 · see citing works

Identification of a series of CCK-2 receptor nonpeptide agonists: Sensitivity to stereochemistry and a receptor point mutation

Kopin, A. S., McBride, E. W., Chen, C., Freidinger, R. M., Chen, D., Zhao, C., & Beinborn, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831223100 · Cited by 17 · see citing works

Cholecystokinin-B receptor gene expression in cerebellum, pre-frontal cortex and cingulate gyrus and its association with suicide

Sherrin, T., Heng, K. Y. C., Zhu, Y. Z., Tang, Y. M., Lau, G., & Tan, C. H. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.072 · Cited by 17 · see citing works

Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze

Kõks, S., Soosaar, A., Võikar, V., Volke, V., Ustav, M., Männistö, P. T., Bourin, M., & Vasar, E. (1998) · Neuropeptides · doi:10.1016/s0143-4179(98)90042-7 · Cited by 16 · see citing works

Role of fluidity of membranes on the guanyl nucleotide-dependent binding of cholecystokinin-8S to rat brain cortical membranes

Rinken, A., Harro, J., Engström, L., & Oreland, L. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00479-6 · Cited by 15 · see citing works

Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine

O’Leary, A., & Harro, J. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.09.006 · Cited by 14 · see citing works

"Anxiety Peptide" Found in Brain

Marx, J. L. (1985) · Science · doi:10.1126/science.2982215 · Cited by 13 · see citing works

Cholecystokinin and panic disorder

Bourin, M., & Dailly, É. (2004) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2004.0076.x · Cited by 12 · see citing works

Involvement of brain endogenous cholecystokinin in stress-induced impairment of spatial recognition memory

Daugé, V., Pophillat, M., Crété, D., Parsadaniantz, S. M., & Roques, B. P. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00932-6 · Cited by 12 · see citing works

New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454

Bellier, B., Crété, D., Million, M., Beslot, F., Bado, A., Garbay, C., & Daug�, V. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0969-7 · Cited by 11 · see citing works

Delayed stress-induced increase in tissue level of cholecystokinin in rat prefrontal cortex: modulation by microdialysis probe implantation and systemic ketamine

Radu, D., Brodin, E., Weber, G., & Lindefors, N. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02648-8 · Cited by 11 · see citing works

Genetic variations in CCK₂ receptor in PVG hooded and Sprague-Dawley rats and its mRNA expression on cat exposure.

Wang, H., Zhu, Y. Z., Farook, J. M., Moochhala, S., Teo, A. L., Lee, L. K. H., & Wong, P. T. ‐. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.2.385 · Cited by 11 · see citing works

Priming pattern determines the correlation between hippocampal theta activity and locomotor stepping elicited by stimulation in anesthetized rats

Sinnamon, H. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00145-7 · Cited by 11 · see citing works

Introduction

Rehfeld, J. F. (1992) · doi:10.1093/oso/9780198577560.003.0010 · Cited by 10 · see citing works

SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI

Shilling, P. D., & Feifel, D. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1214-z · Cited by 9 · see citing works

Neuroanatomical and Pharmacological Evidence for a Functional Interaction Between GABAergic and NPY-Y1 Transmission in the Amygdala of Y1R/LacZ Transgenic Mice

Eva, C. E., Mele, P., Oberto, A., Panzica, G., Pisu, M. G., & Serra, M. (2004) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v16.i12.30 · Cited by 7 · see citing works

Brain neuropeptide Y (NPY) system: a candidate target for treatment of anxiety, depression and alcohol dependence

Heilig, M. A. (2004) · Drugs of the Future · doi:10.1358/dof.2004.029.02.850944 · Cited by 5 · see citing works

Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders

Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00044 · Cited by 1,189 · see citing works

Animals, anxiety, and anxiety disorders: How to measure anxiety in rodents and why

Harro, J. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.10.016 · Cited by 112 · see citing works

Neuropeptides in epilepsy

Kovac, S., & Walker, M. C. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.015 · Cited by 112 · see citing works

CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype

Busquet, P., Nguyen, N. K., Schmid, E., Tanimoto, N., Seeliger, M. W., Ben‐Yosef, T., Mizuno, F., Akopian, A., Striessnig, J., & Singewald, N. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990368 · Cited by 109 · see citing works

Current animal models of anxiety, anxiety disorders, and anxiolytic drugs

Haller, J., & Alicki, M. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32834de34f · Cited by 105 · see citing works

Cholecystokinin: A multi‐functional molecular switch of neuronal circuits

Lee, S. Y., & Soltész, I. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20815 · Cited by 84 · see citing works

Stress-induced changes in primate prefrontal profiles of gene expression

Karssen, A. M., Her, S., Li, J. Z., Patel, P. D., Meng, F., Bunney, W. E., Jones, E. G., Watson, S. J., Akil, H., Myers, R., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002095 · Cited by 82 · see citing works

Neuropeptide Y Y2 receptor in health and disease

Parker, S. L., & Balasubramaniam, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707445 · Cited by 81 · see citing works

Functional Interactions between Endocannabinoid and CCK Neurotransmitter Systems May Be Critical for Extinction Learning

Chhatwal, J. P., Gutman, A. R., Maguschak, K. A., Bowser, M. E., Yang, Y., Davis, M., & Ressler, K. J. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.97 · Cited by 80 · see citing works

Molecular Genetic Findings in Suicidal Behavior: What is Beyond the Serotonergic System?

Rujescu, D., Thalmeier, A., Möller, H., Bronisch, T., & Giegling, I. (2006) · Archives of Suicide Research · doi:10.1080/13811110600897317 · Cited by 79 · see citing works

Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice

Painsipp, E., Wultsch, T., Edelsbrunner, M. E., Tasan, R. O., Singewald, N., Herzog, H., & Holzer, P. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00389.x · Cited by 79 · see citing works

Enteroendocrine hormones – central effects on behavior

Skibicka, K. P., & Dickson, S. L. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.004 · Cited by 69 · see citing works

Cell-Type-Specific CCK2 Receptor Signaling Underlies the Cholecystokinin-Mediated Selective Excitation of Hippocampal Parvalbumin-Positive Fast-Spiking Basket Cells

Lee, S. Y., Földy, C., Szabadics, J., & Soltész, I. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1970-11.2011 · Cited by 61 · see citing works

Endogenously Released Neuropeptide Y Suppresses Hippocampal Short-Term Facilitation and Is Impaired by Stress-Induced Anxiety

Li, Q., Bartley, A. F., & Dobrunz, L. E. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2599-16.2016 · Cited by 55 · see citing works

In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor

Shoblock, J. R., Welty, N., Nepomuceno, D. H., Lord, B., Aluisio, L. E., Fraser, I. C., Motley, S. T., Sutton, S. W., Morton, K. L., Galici, R., et al. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1726-x · Cited by 55 · see citing works

The Role of Neuropeptides in Suicidal Behavior: A Systematic Review

Serafini, G., Pompili, M., Lindqvist, D., Dwivedi, Y. K., & Girardi, P. (2013) · BioMed Research International · doi:10.1155/2013/687575 · Cited by 49 · see citing works

Cholecystokinin enhances GABAergic inhibitory transmission in basolateral amygdala

Chung, L., & Moore, S. D. (2007) · Neuropeptides · doi:10.1016/j.npep.2007.08.001 · Cited by 46 · see citing works

Genes differentially expressed in CB1 knockout mice: Involvement in the depressive-like phenotype

Aso, E., Ozaita, A., Serra, M.-À., & Maldonado, R. J. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.06.007 · Cited by 46 · see citing works

Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression

Paschos, K. A., Veletza, S. V., & Chatzaki, Ε. (2009) · CNS Drugs · doi:10.2165/11310830-000000000-00000 · Cited by 36 · see citing works

Serotonin and the Neurobiology of Anxious States

Lowry, C. A., & Hale, M. W. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70091-6 · Cited by 36 · see citing works

Brain regional neuropeptide changes resulting from social defeat.

Panksepp, J., Burgdorf, J. S., Beinfeld, M. C., Kroes, R. A., & Moskal, J. R. (2007) · Behavioral Neuroscience · doi:10.1037/0735-7044.121.6.1364 · Cited by 35 · see citing works

Micellar nanomedicine of human neuropeptide Y

Kuzmis, A., Lim, S. B., Desai, E., Jeon, E., Lee, B.-S., Rubinstein, I., & Önyüksel, H. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.01.004 · Cited by 32 · see citing works

Excitation of Diverse Classes of Cholecystokinin Interneurons in the Basal Amygdala Facilitates Fear Extinction

Rovira-Esteban, L., Gunduz‐Cinar, O., Bukalo, O., Limoges, A., Brockway, E. T., Müller, K., Fenno, L. E., Kim, Y. S., Ramakrishnan, C., Andrási, T., et al. (2019) · eNeuro · doi:10.1523/eneuro.0220-19.2019 · Cited by 32 · see citing works

Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat

Trent, N. L., & Menard, J. L. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.009 · Cited by 32 · see citing works

Enhanced susceptibility to stress and seizures in GAD65 deficient mice

Qi, J., Kim, M., Sanchez, R. M., Ziaee, S. M., Kohtz, J. D., & Koh, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191794 · Cited by 30 · see citing works

Vanishing clinical psychopharmacology

van Gerven, J., & Cohen, A. F. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04021.x · Cited by 28 · see citing works

Altered neuropeptide Y and neurokinin messenger RNA expression and receptor binding in stress-sensitised rats

de Lange, R. P. J., Wiegant, V. M., & Stam, R. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.018 · Cited by 27 · see citing works

Changes In Plasma NPY, IL-1β And Hypocretin In People Who Died By Suicide

Lü, J., Li, S., Li, H., Mou, T., Zhou, L., Huang, B., Huang, M., & Xu, Y. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s219962 · Cited by 25 · see citing works

Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat

Ballaz, S., Bourin, M., Akil, H., & Watson, S. J. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109761 · Cited by 24 · see citing works

Cholecystokinin system genes: Associations with panic and other psychiatric disorders

Wilson, J., Markie, D., & Fitches, A. C. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.09.011 · Cited by 22 · see citing works

Blockade of CRF1 and CCK2 receptors attenuated the elevated anxiety-like behavior induced by immobilization stress

Wang, H., Spiess, J., Wong, P. T. ‐., & Zhu, Y. Z. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.022 · Cited by 21 · see citing works

An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13

Wang, H. H., Portincasa, P., Liu, M., Tso, P., & Wang, D. Q. ‐. (2020) · Genes · doi:10.3390/genes11121438 · Cited by 19 · see citing works

Substance P, NPY, CCK and their receptors in five brain regions in major depressive disorder with transcriptomic analysis of locus coeruleus neurons

Barde, S. S., Benitez, J. A., Zhong, W., Solarz, A., Mei, I., Prud’homme, J., Palkovits, M., Turecki, G., Mulder, J., Uhlén, M., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.09.004 · Cited by 26 · see citing works

Naturally occurring variations in defensive burying behavior are associated with differences in vasopressin, oxytocin, and androgen receptors in the male rat

Linfoot, I., Gray, M. E., Bingham, B., Williamson, M., Pinel, J. P. J., & Viau, V. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.008 · Cited by 17 · see citing works

Pharmacological and methodological aspects of the separation-induced vocalization test in guinea pig pups; a systematic review and meta-analysis

Groenink, L., Verdouw, P. M., Bakker, B., & Wever, K. E. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.062 · Cited by 17 · see citing works

Cholecystokinin (CCK) level is higher among first time suicide attempters than healthy controls, but is not associated with higher depression scores

Jahangard, L., Solgy, R., Salehi, I., Taheri, S. K., Holsboer‐Trachsler, E., Haghighi, M., & Brand, S. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.05.031 · Cited by 16 · see citing works

Topical Cholecystokinin Depresses Itch-Associated Scratching Behavior in Mice

Fukamachi, S., Mori, T., Sakabe, J., Shiraishi, N., Kuroda, E., Kobayashi, M., Bito, T., Kabashima, K., Nakamura, M., & TOKURA, Y. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.413 · Cited by 15 · see citing works

Lateral septal infusions of the neuropeptide Y Y2 receptor agonist, NPY13–36 differentially affect different defensive behaviors in male, Long Evans rats

Trent, N. L., & Menard, J. L. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.12.011 · Cited by 14 · see citing works

Social Fear Affects Limbic System Neuronal Activity and Gene Expression

Hamann, C. S., Bankmann, J., Maza, H. M., Kornhuber, J., Zoicas, I., & Schmitt-Böhrer, A. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158228 · Cited by 13 · see citing works

Neuropeptides in anxiety and depression

Landgraf, R. (2006) · Amino Acids · doi:10.1007/s00726-006-0327-9 · Cited by 10 · see citing works

Exploring the association between a cholecystokinin promoter polymorphism (rs1799923) and posttraumatic stress disorder in combat veterans

Badour, C. L., Hirsch, R., Zhang, J., Mandel, H., Hamner, M. B., & Wang, Z. (2015) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2015.09.009 · Cited by 9 · see citing works

Angststörungen

Domschke, K., Kapfhammer, H., & Deckert, J. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_69 · Cited by 8 · see citing works

Effects of High-Dose Genistein on the Hypothalamic RNA Profile and Intestinal Health of Female Chicks

Lv, Z., Hu, C., Jiang, J., Jin, S. H., Wei, Q., Wei, X., Yu, D., & Shi, F. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05162 · Cited by 6 · see citing works

Expression of substance P, NPY and their Receptors Is Altered in Major DepressionPreprint

Barde, S. S., Benitez, J. A., Zhong, W., Solarz, A., Mei, I., Prud’homme, J., Palkovits, M., Turecki, G., Mulder, J., Uhlén, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.14.516867 · Cited by 6 · see citing works

Relationship between respiratory, endocrine, and cognitive-emotional factors in response to a pharmacological panicogen

Lyubkin, M., Giardino, N. D., & Abelson, J. L. (2010) · Depression and Anxiety · doi:10.1002/da.20725 · Cited by 5 · see citing works

Cholecystokinin B receptor gene polymorphism (rs2941026) is associated with anxious personality and suicidal thoughts in a longitudinal study

Lvovs, A., Matrov, D., Kurrikoff, T., Veidebaum, T., & Harro, J. (2021) · Acta Neuropsychiatrica · doi:10.1017/neu.2021.41 · Cited by 4 · see citing works

Interaction between cholecystokinin and the fibroblast growth factor system in the ventral tegmental area of selectively bred high- and low-responder rats

Ballaz, S., Perez, J., Waselus, M., Akil, H., & Watson, S. J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.063 · Cited by 3 · see citing works

Angststörungen

Domschke, K., Kapfhammer, H., & Deckert, J. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_69-1 · Cited by 2 · see citing works

Antidepressant‐ and Anxiolytic‐Like Effect of the Froriepia subpinnata Extract in the Rat: Neurochemical Correlates

Samandari-Bahraseman, M. R., Esmaeilzadeh‐Salestani, K., Dogani, M., Khaleghdoust, B., Hatami, N., Esmaeili‐Mahani, S., Elyasi, L., Loit, E., & Harro, J. (2024) · Brain and Behavior · doi:10.1002/brb3.70171 · Cited by 2 · see citing works

Stress, Anxiety, and Cocaine Abuse

Craige, C. P., Enman, N. M., & Unterwald, E. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00006-x · Cited by 1 · see citing works

Biomarkers and Surrogate Markers in Drug Development

Cutler, N. R., Sramek, J. J., Murphy, M. F., Riordan, H., Bieck, P. R., & Carta, A. (2010) · Wiley eBooks · doi:10.1002/9781444318579.ch4

Animal Models and Procedures for CNS Disorders

Cutler, N. R., Sramek, J. J., Murphy, M. F., Riordan, H., Bieck, P. R., & Carta, A. (2010) · Wiley eBooks · doi:10.1002/9781444318579.ch2

Neuropeptides: Active Neuromodulators Involved in the Pathophysiology of Suicidal Behavior and Major Affective Disorders

Serafini, G., Lindqvist, D., Brundin, L., Dwivedi, Y., Girardi, P., & Amore, M. (2014) · Wiley eBooks · doi:10.1002/9783527684403.ch15

Lateral Septal Regulation of Anxiety

Trent, N. L. (2012) · QSpace (Queen's University Library)

Ärevushäirete psühhofarmakoloogia Schmiedebergist homseni

Harro, J. (2014) · Ajakirjad. Journals by UT · doi:10.15157/ea.v0i0.11378

Centrally acting cholecystokinin induces depressor circulatory effects in haemorrhage-shocked rats

Jasikowska, K., Zajac, M., & Jochem, J. (2021) · Annales Academiae Medicae Silesiensis · doi:10.18794/aams/128334

Angststörungen

Kapfhammer, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_57

Cholecystokinins

Harro, J. (2014) · Springer eBooks · doi:10.1007/978-3-642-27772-6_389-2

Cholecystokinins

Harro, J. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_389

Cholecystokinins

Harro, J. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_389

Envolvimento das neurotransmissões glutamatérgica e nitrérgica da substância cinzenta periaquedutal dorsolateral e do núcleo pré-mamilar dorsal na elaboração de respostas defensivas

de Aguiar, D. C. (2008) · doi:10.11606/t.17.2008.tde-06052024-105832

Implication du BDNF dans l'étiopathogenèse et le traitement des troubles anxio-dépressifs : aspects précliniques.

Ibargüen-Vargas, Y. (2008) · theses.fr (ABES) · doi:10.70675/2d73c017z46fcz4c35z8397zb504072e069a

Angst- oder furchtbezogene Störungen

Domschke, K., & Zwanzger, P. (2026) · Springer Reference Medizin · doi:10.1007/978-3-642-45028-0_69-2

Anxiogenic Drug Effects in Behavioral Test Batteries: A Pharmacological Translational Approach

Harro, J., & Kanarik, M. (2026) · Neuromethods · doi:10.1007/978-1-0716-5599-3_2

Is There a Future for Neuropeptide Receptor Ligands in the Treatment of Anxiety Disorders?

Griebel, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00041-2 · Cited by 171 · see citing works

Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice

Desai, S. J., Borkar, C. D., Nakhate, K. T., Subhedar, N. K., & Kokare, D. M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.062 · Cited by 50 · see citing works

Neuropeptides and anxiety: focus on cholecystokinin

Lydiard, R. B. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.2.315 · Cited by 50 · see citing works

Neuropeptides and anxiety disorders

van Megen, H. J. G. M., den Boer, J. A., & Westenberg, H. G. M. (1992) · Acta Neuropsychiatrica · doi:10.1017/s0924270800034864 · Cited by 3 · see citing works

P-7-5 Would CCK-4 challenges be useful to predict anti-anxiety effects of non anti-panic drugs?

Boulenger, J.-P., Jerabek, I., Côté, G., Lavallée, Y. J., & JOLICOEUR, F. B. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)90668-4